Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia

Authors: Jessica Quah, Boran Jiang, Poh Choo Tan, Chuin Siau, Thean Yen Tan

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

The impact of different classes of microbial pathogens on mortality in severe community-acquired pneumonia is not well elucidated. Previous studies have shown significant variation in the incidence of viral, bacterial and mixed infections, with conflicting risk associations for mortality. We aimed to determine the risk association of microbial aetiologies with hospital mortality in severe CAP, utilising a diagnostic strategy incorporating molecular testing. Our primary hypothesis was that respiratory viruses were important causative pathogens in severe CAP and was associated with increased mortality when present with bacterial pathogens in mixed viral-bacterial co-infections.

Methods

A retrospective cohort study from January 2014 to July 2015 was conducted in a tertiary hospital medical intensive care unit in eastern Singapore, which has a tropical climate. All patients diagnosed with severe community-acquired pneumonia were included.

Results

A total of 117 patients were in the study. Microbial pathogens were identified in 84 (71.8%) patients. Mixed viral-bacterial co-infections occurred in 18 (15.4%) of patients. Isolated viral infections were present in 32 patients (27.4%); isolated bacterial infections were detected in 34 patients (29.1%). Hospital mortality occurred in 16 (13.7%) patients. The most common bacteria isolated was Streptococcus pneumoniae and the most common virus isolated was Influenza A. Univariate and multivariate logistic regression showed that serum procalcitonin, APACHE II severity score and mixed viral-bacterial infection were associated with increased risk of hospital mortality. Mixed viral-bacterial co-infections were associated with an adjusted odds ratio of 13.99 (95% CI 1.30–151.05, p = 0.03) for hospital mortality.

Conclusions

Respiratory viruses are common organisms isolated in severe community-acquired pneumonia. Mixed viral-bacterial infections may be associated with an increased risk of mortality.
Literature
1.
go back to reference Khawaja A, Zubairi ABS, Durrani FK, et al. Etiology and outcome of severe community acquired pneumonia in immunocompetent adults. BMC Infect Dis. 2013;13:94.CrossRefPubMedPubMedCentral Khawaja A, Zubairi ABS, Durrani FK, et al. Etiology and outcome of severe community acquired pneumonia in immunocompetent adults. BMC Infect Dis. 2013;13:94.CrossRefPubMedPubMedCentral
2.
go back to reference Holter JC, Müller F, Bjørang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.CrossRefPubMedPubMedCentral Holter JC, Müller F, Bjørang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.CrossRefPubMedPubMedCentral
3.
go back to reference Garibaldi RA, et al. Epidemiology of community-acquired respiratory tract infections in adults. Am J Med. 1985;78(6):32–7.CrossRefPubMed Garibaldi RA, et al. Epidemiology of community-acquired respiratory tract infections in adults. Am J Med. 1985;78(6):32–7.CrossRefPubMed
4.
go back to reference Sakr Y, Ferrer R, Reinhart K, et al. The intensive care global study on severe acute respiratory infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. Intensive Care Med. 2016;42:817–28.CrossRefPubMed Sakr Y, Ferrer R, Reinhart K, et al. The intensive care global study on severe acute respiratory infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. Intensive Care Med. 2016;42:817–28.CrossRefPubMed
5.
go back to reference Voiriot G, Visseaux B, Cohen J, et al. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care. 2016;20:375.CrossRefPubMedPubMedCentral Voiriot G, Visseaux B, Cohen J, et al. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care. 2016;20:375.CrossRefPubMedPubMedCentral
6.
go back to reference Somerville LK, Mala Ratnamohan V, Dwyer DE, et al. Molecular diagnosis of respiratory viruses. Pathology. 2015;47:243–9.CrossRefPubMed Somerville LK, Mala Ratnamohan V, Dwyer DE, et al. Molecular diagnosis of respiratory viruses. Pathology. 2015;47:243–9.CrossRefPubMed
7.
go back to reference Babady NE, et al. The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn. 2013;13(8):779–88.CrossRefPubMed Babady NE, et al. The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn. 2013;13(8):779–88.CrossRefPubMed
8.
go back to reference Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the emergency department. Cochrane Database Syst Rev. 2014;15(9):CD006452. Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the emergency department. Cochrane Database Syst Rev. 2014;15(9):CD006452.
9.
go back to reference Green DA, Hitoaliaj L, Kotansky B, et al. Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol. 2016;54(12):2950–5.CrossRefPubMedPubMedCentral Green DA, Hitoaliaj L, Kotansky B, et al. Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol. 2016;54(12):2950–5.CrossRefPubMedPubMedCentral
10.
go back to reference Schnell D, Gits-Muselli M, Canet E, et al. Burden of respiratory viruses in patients with acute respiratory failure. J Med Virol. 2014;86(7):1198–202.CrossRefPubMed Schnell D, Gits-Muselli M, Canet E, et al. Burden of respiratory viruses in patients with acute respiratory failure. J Med Virol. 2014;86(7):1198–202.CrossRefPubMed
11.
go back to reference Cillóniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care. 2011;15(5):R209.CrossRefPubMedPubMedCentral Cillóniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care. 2011;15(5):R209.CrossRefPubMedPubMedCentral
12.
go back to reference Echenique IA, Chan PA, Chapin KC, et al. Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic. PLoS One. 2013;8(4):e60845.CrossRefPubMedPubMedCentral Echenique IA, Chan PA, Chapin KC, et al. Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic. PLoS One. 2013;8(4):e60845.CrossRefPubMedPubMedCentral
13.
go back to reference Salluh JI, Lisboa T, Bozza FA, et al. Management of severe community-acquired pneumonia: a survey on the attitudes of 468 physicians in Iberia and South America. J Crit Care. 2014;29(5):743–7.CrossRefPubMed Salluh JI, Lisboa T, Bozza FA, et al. Management of severe community-acquired pneumonia: a survey on the attitudes of 468 physicians in Iberia and South America. J Crit Care. 2014;29(5):743–7.CrossRefPubMed
14.
go back to reference Van Someren Gréve F, Ong DS, Cremer OL, et al. Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: a prospective observational study. J Clin Virol. 2016;83:37–42.CrossRefPubMed Van Someren Gréve F, Ong DS, Cremer OL, et al. Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: a prospective observational study. J Clin Virol. 2016;83:37–42.CrossRefPubMed
15.
go back to reference Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the Management of Community-Acquired Pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.CrossRefPubMed Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the Management of Community-Acquired Pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.CrossRefPubMed
16.
go back to reference Khalid I, Alraddadi BM, Dairi Y, et al. Acute management and long-term survival among subjects with severe Middle East respiratory syndrome coronavirus pneumonia and ARDS. Respir Care. 2016;61(3):340–8.CrossRefPubMed Khalid I, Alraddadi BM, Dairi Y, et al. Acute management and long-term survival among subjects with severe Middle East respiratory syndrome coronavirus pneumonia and ARDS. Respir Care. 2016;61(3):340–8.CrossRefPubMed
17.
go back to reference Luyt CE, Combes A, Trouillet JL, et al. Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome. La Presse Médicale. 2011;40(12 Pt 2):e561–8.CrossRefPubMed Luyt CE, Combes A, Trouillet JL, et al. Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome. La Presse Médicale. 2011;40(12 Pt 2):e561–8.CrossRefPubMed
18.
go back to reference Töpfer L, Menk M, Weber-Carstens S, et al. Influenza a (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014;29(3):340–6.CrossRefPubMed Töpfer L, Menk M, Weber-Carstens S, et al. Influenza a (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014;29(3):340–6.CrossRefPubMed
19.
go back to reference Fisher K, Trupka T, Micek ST, et al. A prospective one-year microbiologic survey of combined pneumonia and respiratory failure. Surg Infect. 2017;18(7):827–33.CrossRef Fisher K, Trupka T, Micek ST, et al. A prospective one-year microbiologic survey of combined pneumonia and respiratory failure. Surg Infect. 2017;18(7):827–33.CrossRef
20.
go back to reference Siow WT, Koay ES, Lee CK, et al. The use of polymerase chain reaction amplification for the detection of viruses and Bacteria in severe community-acquired pneumonia. Respiration. 2016;92(5):286–94.CrossRefPubMed Siow WT, Koay ES, Lee CK, et al. The use of polymerase chain reaction amplification for the detection of viruses and Bacteria in severe community-acquired pneumonia. Respiration. 2016;92(5):286–94.CrossRefPubMed
21.
go back to reference Finch S, Keir HR, Dicker AJ, et al. The past decade in bench research into pulmonary infectious diseases: what do clinicians need to know? Respirology. 2017;22(6):1062–72.CrossRefPubMed Finch S, Keir HR, Dicker AJ, et al. The past decade in bench research into pulmonary infectious diseases: what do clinicians need to know? Respirology. 2017;22(6):1062–72.CrossRefPubMed
22.
go back to reference Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016;48(6):1764–78.CrossRefPubMed Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016;48(6):1764–78.CrossRefPubMed
23.
go back to reference Piralla A, Mariani B, Rovida F, et al. Frequency of respiratory viruses among patients admitted to 26 intensive care units in seven consecutive winter-spring seasons (2009–2016) in northern Italy. J Clin Virol. 2017;92:48–51.CrossRefPubMed Piralla A, Mariani B, Rovida F, et al. Frequency of respiratory viruses among patients admitted to 26 intensive care units in seven consecutive winter-spring seasons (2009–2016) in northern Italy. J Clin Virol. 2017;92:48–51.CrossRefPubMed
24.
go back to reference Ang LW, Tien WS, Lin RT, et al. Characterization of influenza activity based on virological surveillance of influenza-like illness in tropical Singapore, 2010-2014. J Med Virol. 2016;88(12):2069–77.CrossRefPubMed Ang LW, Tien WS, Lin RT, et al. Characterization of influenza activity based on virological surveillance of influenza-like illness in tropical Singapore, 2010-2014. J Med Virol. 2016;88(12):2069–77.CrossRefPubMed
25.
26.
go back to reference Shinya K, Gao Y, Cilloniz C, et al. Integrated clinical, pathologic, Virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol. 2012;86(11):6055–66.CrossRefPubMedPubMedCentral Shinya K, Gao Y, Cilloniz C, et al. Integrated clinical, pathologic, Virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol. 2012;86(11):6055–66.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Memish ZA, Almasri M, Turkestani A, et al. Etiology of severe community-acquired pneumonia during the 2013 hajj—part of the MERS-CoV surveillance program. Int J Infect Dis. 2014;25:186–90.CrossRefPubMed Memish ZA, Almasri M, Turkestani A, et al. Etiology of severe community-acquired pneumonia during the 2013 hajj—part of the MERS-CoV surveillance program. Int J Infect Dis. 2014;25:186–90.CrossRefPubMed
29.
go back to reference Choi SH, Hong SB, Kim T, et al. Clinical and molecular characterization of rhinoviruses a, B, and C in adult patients with pneumonia. J Clin Virol. 2015;63:70–5.CrossRefPubMed Choi SH, Hong SB, Kim T, et al. Clinical and molecular characterization of rhinoviruses a, B, and C in adult patients with pneumonia. J Clin Virol. 2015;63:70–5.CrossRefPubMed
30.
go back to reference Principi N, Daleno C, Esposito S, et al. Human rhinoviruses and severe respiratory infections: is it possible to identify at-risk patients early? Expert Rev Anti-Infect Ther. 2014;12(4):423–30.CrossRefPubMed Principi N, Daleno C, Esposito S, et al. Human rhinoviruses and severe respiratory infections: is it possible to identify at-risk patients early? Expert Rev Anti-Infect Ther. 2014;12(4):423–30.CrossRefPubMed
31.
go back to reference Shah RD. Wunderink, et al: viral pneumonia and acute respiratory distress syndrome. Clin Chest Med. 2017;38(1):113–25.CrossRefPubMed Shah RD. Wunderink, et al: viral pneumonia and acute respiratory distress syndrome. Clin Chest Med. 2017;38(1):113–25.CrossRefPubMed
32.
go back to reference Abubakar A, Malik M, Pebody RG, et al. Burden of acute respiratory disease of epidemic and pandemic potential in the WHO eastern Mediterranean region: a literature review. East Mediterr Health J. 2016;22(7):509–22.CrossRef Abubakar A, Malik M, Pebody RG, et al. Burden of acute respiratory disease of epidemic and pandemic potential in the WHO eastern Mediterranean region: a literature review. East Mediterr Health J. 2016;22(7):509–22.CrossRef
33.
go back to reference Widdowson MA, Bresee JS, Jernigan DB, et al. Global threat of animal influenza viruses of zoonotic concern: then and now. J Infect Dis. 2017;216(suppl_4):S493–8.CrossRefPubMed Widdowson MA, Bresee JS, Jernigan DB, et al. Global threat of animal influenza viruses of zoonotic concern: then and now. J Infect Dis. 2017;216(suppl_4):S493–8.CrossRefPubMed
34.
go back to reference Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis campaign: international guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39(2):165–228.CrossRefPubMed Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis campaign: international guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39(2):165–228.CrossRefPubMed
35.
go back to reference Welte T, Köhnlein T, et al. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ network. Semin Respir Crit Care Med. 2009;30(2):127–35.CrossRefPubMed Welte T, Köhnlein T, et al. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ network. Semin Respir Crit Care Med. 2009;30(2):127–35.CrossRefPubMed
36.
go back to reference Wiemken TL, Peyrani P, Ramirez JA, et al. Global changes in the epidemiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33(3):213–9.CrossRefPubMed Wiemken TL, Peyrani P, Ramirez JA, et al. Global changes in the epidemiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33(3):213–9.CrossRefPubMed
37.
38.
go back to reference Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–23.CrossRefPubMedPubMedCentral Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–23.CrossRefPubMedPubMedCentral
39.
go back to reference Tseng YT, Chuang YC, Shu CC, et al. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia. Crit Care. 2012;16(5):R207.CrossRefPubMedPubMedCentral Tseng YT, Chuang YC, Shu CC, et al. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia. Crit Care. 2012;16(5):R207.CrossRefPubMedPubMedCentral
40.
go back to reference Pereira JM, Gonçalves-Pereira J, Ribeiro O, et al. Impact of antibiotic therapy in severe community-acquired pneumonia: data from the Infauci study. J Crit Care. 2017;43:183–9.CrossRefPubMed Pereira JM, Gonçalves-Pereira J, Ribeiro O, et al. Impact of antibiotic therapy in severe community-acquired pneumonia: data from the Infauci study. J Crit Care. 2017;43:183–9.CrossRefPubMed
41.
go back to reference Sirvent JM, Carmen de la Torre M, Lorencio C, et al. Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24h of ICU admission. Med Int. 2013;37(5):308–15. Sirvent JM, Carmen de la Torre M, Lorencio C, et al. Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24h of ICU admission. Med Int. 2013;37(5):308–15.
42.
go back to reference Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186(4):325–32.CrossRefPubMed Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186(4):325–32.CrossRefPubMed
43.
go back to reference El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med. 2001;163(3):645–51.CrossRefPubMed El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med. 2001;163(3):645–51.CrossRefPubMed
44.
go back to reference Pascual FE, Matthay MA, Bacchetti P, et al. Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest. 2000;117(2):503–12.CrossRefPubMed Pascual FE, Matthay MA, Bacchetti P, et al. Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest. 2000;117(2):503–12.CrossRefPubMed
Metadata
Title
Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
Authors
Jessica Quah
Boran Jiang
Poh Choo Tan
Chuin Siau
Thean Yen Tan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3366-4

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue